Thrombospondin-4 Ala387Pro polymorphism is not associated with vascular function and risk of coronary heart disease in US men and women

Folkert W. Asselbergs; Jennifer K. Pai; Tobias Pischon; JoAnn E. Manson; Eric B. Rimm

doi:10.1160/TH05-12-0806

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2006; 95(03): 589-590
DOI: 10.1160/TH05-12-0806

Letters to the Editor

Schattauer GmbH

Thrombospondin-4 Ala387Pro polymorphism is not associated with vascular function and risk of coronary heart disease in US men and women

Folkert W. Asselbergs

¹Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA

⁵Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands

,

Jennifer K. Pai

¹Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA

²Division of Preventive Medicine Boston, Massachusetts, USA

,

Tobias Pischon

⁴Department of Epidemiology, German Institute of Human Nutrition, Postdam-Rehbruecke, Germany

,

JoAnn E. Manson

¹Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA

²Division of Preventive Medicine Boston, Massachusetts, USA

,

Eric B. Rimm

¹Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA

³Charming Laboratory, Department of Medicine, Brigham & Women’s Hospital, and Harvard Medical School, Boston, Massachusetts, USA

References
1 Stenina OI. et al. Thrombospondin-4 and its variants: expression and differential effects on endothelial cells. Circulation 2003; 108: 1514-9.
2 Topol EJ. et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 2001; 104: 2641-4.
3 McCarthy JJ. et al. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet 2004; 41: 334-41.
4 Boekholdt SM. et al. Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 2002; 22: e24-e27.
5 Yamada Y. et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347: 1916-23.
6 Zhou X. et al. Thrombospondin-4 A387P polymorphism is not associated with coronary artery disease and myocardial infarction in the Chinese Han population. Clin Sci (Lond) 2004; 106: 495-500.
7 Cui J. et al. Gender dependent association of thrombospondin-4 A387P polymorphism with myocardial infarction. Arterioscler Thromb Vasc Biol 2004; 24: el83-el84.
8 Wessel J. et al. Replication of the association between the thrombospondin-4 A387P polymorphism and myocardial infarction. Am Heart J 2004; 147: 905-9.
9 Pischon T. et al. Peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and risk of coronary heart disease in US men and women. Arterioscler Thromb Vasc Biol 2005; 25: 1654-8.
10 Meigs JB. et al. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004; 291: 1978-86.
11 Lewis CM. Genetic association studies: design. analysis and interpretation. Brief Bioinform 2002; 03: 146-53.